SpinaFX Medical
Brian McDonald serves as the Head of Finance and Governance at R-LABS Canada Inc. and has held multiple roles as a Fractional CFO at several companies, including OneClose, SpinaFX, Northern Biologics, and BlueRock Therapeutics. Brian McDonald holds a degree from the Schulich School of Business at York University, where studies were completed from 2003 to 2005.
This person is not in any teams
SpinaFX Medical
SpinaFX is a medical device company bringing innovative, minimally invasive image-guided treatments to patients with back pain due to herniated discs. Our patented technology provides surgeons an earlier alternative to conventional surgery, using a minimally invasive technique to deliver a controlled Oxygen formulation to the affected disc, safelyreducing the herniation and inflammation causing pain. SpinaFX's Triojection™ product was previously CE Marked under MDD and is undergoing re-certification under MDR. Triojection is not yet approved for sale in the North America, the UK or the EU.